Clinical Trials Browser

Phase 1 × Neoplasms × Immunotherapy, Adoptive × Clear all

NCT03696030 2025-04-13

HER2-CAR T Cells in Treating Patients With Recurrent Brain or Leptomeningeal Metastases

Phase 1 Active not recruiting

Brain Neoplasms, Breast Neoplasms, Neoplasms, Meningeal Carcinomatosis